Related Experiment Video
Updated: Dec 9, 2025

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Statins ameliorate cholesterol-induced inflammation and improve AQP2 expression by inhibiting NLRP3 activation in the
Yonglun Kong1,2, Weijing Feng1,3,4, Xiaoduo Zhao2
1Department of Cardiology, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen 518033, China.
Insights
Statins may improve kidney water handling in chronic kidney disease by reducing cholesterol-induced inflammation and promoting aquaporin-2 (AQP2) expression, despite controversial effects on kidney function. This study investigated statin effects on renal AQP2 and NLRP3 inflammasome.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Molecular Biology
Background:
- Chronic kidney disease (CKD) is linked to dyslipidemia, with statins recommended for cardiovascular risk but controversial for kidney disease progression.
- The impact of statins on renal water handling and kidney disease progression remains unclear.
Purpose of the Study:
- To investigate statin treatment effects on renal water handling in patients and animal models with high-fat diet-induced dyslipidemia.
- To examine the relationship between serum cholesterol, aquaporin-2 (AQP2), and the NLRP3 inflammasome in kidney disease.
Main Methods:
- Retrospective analysis of patient kidney biopsy data to assess AQP2 and ASC protein expression.
- In vivo studies using Nlrp3-deficient mice and 5/6 nephrectomized rats on a high-fat diet, treated with statins.
- In vitro experiments to evaluate cholesterol and statin effects on NLRP3 inflammasome components and AQP2.
Main Results:
- Serum cholesterol negatively correlated with estimated glomerular filtration rate (eGFR) and kidney AQP2 expression in patients; statins abolished this correlation without affecting eGFR.
- High-fat diet decreased AQP2 and increased urine output in mice, an effect attenuated by Nlrp3 deficiency.
- Atorvastatin decreased urine output and increased AQP2 in rats; in vitro, cholesterol upregulated NLRP3 components and decreased AQP2, effects prevented by statins via ASC speck degradation.
Conclusions:
- Serum cholesterol negatively impacts kidney AQP2 expression in CKD patients.
- Statins ameliorate cholesterol-induced renal inflammation by promoting ASC speck degradation and improving aquaporin expression in high-fat diet animal models.
Abstract:
Background: Chronic kidney diseases (CKD) are usually associated with dyslipidemia. Statin therapy has been primarily recommended for the prevention of cardiovascular risk in patients with CKD; however, the effects of statins on kidney disease progression remain controversial. This study aims to investigate the effects of statin treatment on renal handling of water in patients and in animals on a high-fat diet. Methods: Retrospective cohort patient data were reviewed and the protein expression levels of aquaporin-2 (AQP2) and NLRP3 inflammasome adaptor ASC were examined in kidney biopsy specimens. The effects of statins on AQP2 and NLRP3 inflammasome components were examined in nlrp3 mice, 5/6 nephroectomized (5/6Nx) rats with a high-fat diet (HFD), and in vitro. Results: In the retrospective cohort study, serum cholesterol was negatively correlated to eGFR and AQP2 protein expression in the kidney biopsy specimens. Statins exhibited no effect on eGFR but abolished the negative correlation between cholesterol and AQP2 expression. Whilst nlrp3 mice showed an increased urine output and a decreased expression of AQP2 protein after a HFD, which was moderately attenuated in nlrp3 deletion mice with HFD. In 5/6Nx rats on a HFD, atorvastatin markedly decreased the urine output and upregulated the protein expression of AQP2. Cholesterol stimulated the protein expression of NLRP3 inflammasome components ASC, caspase-1 and IL-1β, and decreased AQP2 protein abundance in vitro, which was markedly prevented by statins, likely through the enhancement of ASC speck degradation via autophagy. Conclusion: Serum cholesterol level has a negative correlation with AQP2 protein expression in the kidney biopsy specimens of patients. Statins can ameliorate cholesterol-induced inflammation by promoting the degradation of ASC speck, and improve the expression of aquaporin in the kidneys of animals on a HFD.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Inflammation
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis I: Introduction
Peripheral Artery Disease III: Interprofessional Care